))
S2 Ep12: From Infection to Innovation: The Turn Therapeutics Story
Manage episode 422016796 series 3538631
Content provided by The Cutaneous Connection. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Cutaneous Connection or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Bradley Burnam, the founder and CEO of Turn Therapeutics, discusses his journey in the pharmaceutical landscape: from his battle with an aggressive antimicrobial resistant infection to the beginnings of Turn, and to the current state of Hexagen technology and its potential in eczema, onychomycosis, and more.
70 episodes
Share
